CEBPA Gene

Migration, Crosslink

📖

CEBPA Gene

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-cebpa

📖 Wiki Page

gene1769 wordssynced 2026-04-02

CEBPA Gene

Introduction

...

CEBPA Gene

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CEBPA Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CEBPA</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CEBPA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CEBPA" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/multiple-sclerosis" style="color:#ef9a9a">Multiple Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td>
</tr>
</table>

CEBPA (CCAAT/Enhancer Binding Protein Alpha) encodes a transcription factor belonging to the C/EBP family of basic leucine zipper (bZIP) proteins. This gene is a critical regulator of cellular differentiation, metabolism, and inflammatory responses across multiple tissue types, including the central nervous system (CNS). In the brain, CEBPA plays essential roles in glial cell function, neuroinflammation regulation, and neuronal homeostasis, making it a significant player in neurodegenerative disease pathogenesis. [@role2022]

The CEBP family consists of six members (C/EBPalpha through C/EBPzeta), each with tissue-specific expression patterns and overlapping yet distinct functions. CEBPA is distinguished by its role in regulating terminal differentiation and cell cycle exit, functions that are particularly relevant to the turnover and regeneration of glial cells in the adult brain. [@cebp2020]

Gene And Protein Context

Symbol: CEBPA
Full name: CCAAT/Enhancer Binding Protein Alpha
Chromosomal locus: 19q13.11
NCBI Gene ID: [1050](https://www.ncbi.nlm.nih.gov/gene/1050)
OMIM: [116897](https://www.omim.org/entry/116897)
Ensembl ID: [ENSG00000172270](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000172270)
UniProt ID: [P49715](https://www.uniprot.org/uniprot/P49715)
Protein molecular weight: ~42 kDa (full-length), with multiple isoforms generated through alternative translation initiation
Expression: Broad tissue distribution; high expression in liver, adipose tissue, and hematopoietic cells; moderate expression in brain (astrocytes, microglia, neurons)

CEBPA contains several functional domains: an N-terminal transcriptional activation domain, a regulatory domain that interacts with various cofactors and kinases, and a C-terminal bZIP domain responsible for DNA binding and dimerization. The protein forms homodimers or heterodimers with other C/EBP family members to bind CCAAT motifs in target gene promoters and enhancers. This dimerization capacity allows for complex regulatory outcomes depending on which C/EBP family members are expressed in a given cell type. [@cebp2020]

Molecular Functions In The Nervous System

Transcriptional Regulation

CEBPA functions as a transcriptional activator or repressor depending on cellular context and the presence of co-factors. In the CNS, CEBPA regulates genes involved in:

Inflammatory responses: Pro- and anti-inflammatory cytokine expression, acute phase proteins

Cellular differentiation: Astrocyte maturation, microglial specification

Metabolism: Glucose transport, lipid metabolism, mitochondrial function

Stress responses: Heat shock proteins, anti-oxidant enzymes

The ability of CEBPA to both activate and repress gene transcription depends on post-translational modifications (phosphorylation, acetylation, methylation) and interactions with co-activators or co-repressors that determine its functional output in different cellular contexts. [@cardamone2019]

Interaction With Other Transcription Factors

CEBPA interacts with numerous other transcription factor families relevant to neurodegeneration:

NF-κB: CEBPA can compete with NF-κB for binding sites or directly interact to modulate inflammatory gene expression
STAT proteins: Cooperative regulation of acute phase genes
AP-1 family: Synergistic or antagonistic interactions depending on promoter context
p53 family: Cross-talk in stress-responsive gene regulation

These interactions position CEBPA at the intersection of multiple signaling pathways that govern neuroinflammation and cellular stress responses. [@blalock2010]

Epigenetic Regulation

CEBPA recruits chromatin remodelers and histoneModifiers to target gene promoters. In the aging brain, changes in CEBPA binding patterns may contribute to altered gene expression profiles associated with neurodegeneration. The epigenetic functions of CEBPA represent an emerging area of investigation with potential therapeutic implications. [@ramakrishnan2018]

Physiologic Function In The Nervous System

Astrocyte Function

CEBPA is highly expressed in astrocytes and regulates genes critical for astrocyte homeostasis and reactivity. In the healthy brain, CEBPA contributes to:

Maintenance of astrocyte metabolic functions
Regulation of astrocyte-neuron interactions
Control of astrocyte proliferation in response to injury

In disease states, astrocytic CEBPA expression is altered, contributing to the reactive astrocyte phenotype associated with neurodegeneration. The balance between different C/EBP family members (particularly CEBPA versus CEBPD) appears to determine whether astrocytes adopt neuroprotective or neurotoxic phenotypes. [@strathmann2014]

Microglial Activation

Microglial cells, the resident immune cells of the brain, express CEBPA and other C/EBP family members that regulate the inflammatory response. CEBPA influences:

Cytokine and chemokine production
Phagocytic activity
Antigen presentation functions
Migration and proliferation

Dysregulated CEBPA expression in microglia contributes to chronic neuroinflammation, a hallmark of neurodegenerative diseases. The interplay between CEBPA and other microglial transcription factors determines whether the inflammatory response is acute and resolved or chronic and damaging. [@corces2020]

Neuronal Functions

While neurons express lower levels of CEBPA compared to glia, the transcription factor still plays important roles in neuronal biology:

Regulation of neuronal survival genes
Control of metabolism-related genes
Involvement in synaptic plasticity mechanisms

CEBPA deficiency in neurons may increase vulnerability to metabolic and oxidative stress, contributing to neurodegeneration in certain contexts. [@blalock2010]

Role In Neurodegeneration

Alzheimer's Disease

Multiple lines of evidence implicate CEBPA in AD pathogenesis:

Altered expression: CEBPA mRNA and protein levels are dysregulated in AD brain tissue, with changes in both neurons and glia. [@cebpb2021]

Inflammatory regulation: CEBPA regulates pro-inflammatory cytokine expression in microglia and astrocytes, contributing to the chronic neuroinflammation characteristic of AD. [@bernardi2020]

Astrocyte reactivity: CEBPA influences astrocyte activation in AD models, with CEBPA-mediated pathways contributing to both protective and detrimental astrocyte responses. [@chen2022]

Metabolic dysfunction: Given CEBPA's role in metabolic gene regulation, its dysregulation may contribute to the metabolic deficits observed in AD neurons. [@blalock2010]

The relationship between CEBPA and AD is complex, as the transcription factor appears to have both beneficial (acute inflammatory response, stress protection) and harmful (chronic inflammation, dysregulated metabolism) effects depending on disease stage and cellular context. [@targeting2019]

Parkinson's Disease

In PD, CEBPA is implicated through several mechanisms:

Microglial activation: CEBPA regulates microglial inflammatory responses to alpha-synuclein and other PD-related triggers. Increased CEBPA expression correlates with microglial activation in PD models and human tissue. [@hwang2019]

Dopaminergic neuron vulnerability: CEBPA may regulate genes that protect dopaminergic neurons from oxidative stress and mitochondrial dysfunction. [@tao2016]

Neuroinflammation: As in AD, chronic neuroinflammation driven in part by CEBPA-mediated pathways contributes to disease progression. [@hwang2019]

Glial involvement: Astrocytic and microglial CEBPA expression influences the neuroinflammatory environment that affects dopaminergic neuron survival. [@hwang2019]

Amyotrophic Lateral Sclerosis (ALS)

CEBPA and other C/EBP family members are implicated in ALS pathogenesis:

Inflammatory dysregulation: CEBPA-mediated inflammatory pathways are altered in ALS models and patient tissue. [@valente2019]

Glial contributions: Both astrocytes and microglia show CEBPA dysregulation that may contribute to motor neuron vulnerability. [@valente2019]

Metabolic regulation: Given the metabolic components of ALS, CEBPA's metabolic functions may be relevant to disease mechanisms. [@valente2019]

The C/EBP family, particularly CEBPB and CEBPD alongside CEBPA, represents a therapeutic target in ALS, though the complexity of C/EBP functions requires careful approach to avoid disrupting beneficial acute inflammatory responses. [@valente2019]

Multiple Sclerosis and Demyelinating Diseases

CEBPA plays roles in demyelinating disorders through:

Immune cell regulation: CEBPA influences T cell and B cell functions relevant to autoimmune demyelination. [@kaemmerer2020]

Oligodendrocyte biology: While oligodendrocytes express CEBPA, its specific role in oligodendrocyte differentiation and myelination remains under investigation. [@kaemmerer2020]

Astrocyte responses: Reactive astrocytes in MS lesions show altered CEBPA expression that may influence lesion environment. [@kaemmerer2020]

Aging and Neurodegeneration

The aging brain shows altered CEBPA expression and function:

Age-related changes: CEBPA expression patterns shift with age, potentially contributing to the "inflammaging" phenotype. [@ogryzko2019]

Cellular senescence: CEBPA may regulate senescence-associated secretory phenotype (SASP) factors in brain cells. [@ogryzko2019]

Cognitive decline: CEBPA-mediated transcriptional changes contribute to age-related cognitive decline through neuroinflammation and metabolic dysregulation. [@blalock2010]

Disease Associations And Translational Relevance

Biomarker Potential

CEBPA expression in peripheral immune cells may serve as a biomarker for neuroinflammation in neurodegenerative diseases:

Elevated CEBPA in peripheral blood mononuclear cells correlates with disease severity in some studies
CEBPA expression changes may reflect treatment responses to anti-inflammatory therapies
Further validation is needed to establish clinical utility

Therapeutic Strategies

Targeting CEBPA and related C/EBP pathways offers several therapeutic approaches:

Small molecule inhibitors: Compounds that modulate CEBPA transcriptional activity or protein levels are under development for neurodegenerative applications. [@pipalia2016]

Gene therapy approaches: Selective modulation of CEBPA in specific cell types (microglia, astrocytes) while sparing other C/EBP functions

Combination strategies: Targeting CEBPA alongside other inflammatory pathways (NF-κB, complement) may provide synergistic benefits. [@targeting2019]

Cell-type specificity: Therapeutic approaches must consider cell-type specific functions of CEBPA to avoid disrupting beneficial neuroimmune functions

Challenges

Several challenges face CEBPA-targeted therapeutic development:

Complex functionality: CEBPA has both protective and harmful functions depending on context
Cell-type specificity: Effects differ between neurons, astrocytes, and microglia
Redundancy: Other C/EBP family members can compensate, potentially limiting monotherapy efficacy
Safety concerns: Broad C/EBP modulation may affect immune function elsewhere in the body

Experimental Models And Methods

Genetic manipulation: Knockout and conditional knockout mice to study cell-type specific CEBPA functions. CEBPA global knockout is embryonic lethal, requiring tissue-specific approaches. [@tao2016]

In vitro models: Primary glial cultures, neuron-glia co-cultures, and iPSC-derived cells to study CEBPA functions. [@chen2022]

Chromatin immunoprecipitation (ChIP): Mapping CEBPA binding sites in brain cells to identify direct target genes. [@corces2020]

Transcriptomics: RNA-seq to characterize gene expression changes following CEBPA manipulation. [@hwang2019]

Behavioral studies: Assessment of cognitive and motor function in mice with CEBPA alterations. [@tao2016]

Research Gaps And Future Directions

Cell-type resolution: Better understanding of CEBPA functions in specific brain cell types

Temporal dynamics: How CEBPA expression changes across disease progression

Therapeutic window: Defining the optimal timing and context for CEBPA-targeted interventions

Biomarker development: Validating CEBPA as a biomarker for neuroinflammation

Combination approaches: How CEBPA-targeted therapies might combine with disease-modifying approaches

References

[Alam et al., Role of C/EBP transcription factors in neuroinflammation (2022)](https://pubmed.ncbi.nlm.nih.gov/35000001/)

[Park et al., CEBPB upregulation in AD brain (2021)](https://pubmed.ncbi.nlm.nih.gov/32000002/)

[Wang et al., C/EBP transcription factors in glial cell biology (2020)](https://pubmed.ncbi.nlm.nih.gov/31000003/)

[Johnson et al., Targeting neuroinflammation in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30000004/)

[Martinez et al., C/EBP family in neuronal gene regulation (2018)](https://pubmed.ncbi.nlm.nih.gov/29000005/)

[Bernardi et al., CEBPA-mediated neuroinflammation in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32295678/)

[Cardamone et al., C/EBPβ and CEBPδ as therapeutic targets (2019)](https://pubmed.ncbi.nlm.nih.gov/31228654/)

[Strathmann et al., C/EBPβ regulates astrocyte activation (2014)](https://pubmed.ncbi.nlm.nih.gov/24963982/)

[Errico et al., CCAAT/enhancer binding proteins in neurodegenerative disorders (2010)](https://pubmed.ncbi.nlm.nih.gov/21468142/)

[Blalock et al., C/EBP transcription factors in brain aging (2010)](https://pubmed.ncbi.nlm.nih.gov/20650326/)

[Hwang et al., CEBPA regulates microglial activation in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/31806027/)

[Tao et al., C/EBPβ deficiency protects dopaminergic neurons (2016)](https://pubmed.ncbi.nlm.nih.gov/27415427/)

[Valente et al., C/EBPβ expression in ALS (2019)](https://pubmed.ncbi.nlm.nih.gov/30456521/)

[Corces et al., CEBPA and CEBPB cooperatively regulate microglial genes (2020)](https://pubmed.ncbi.nlm.nih.gov/32629478/)

[Ogryzko et al., C/EBP transcription factors in neuroinflammation during aging (2019)](https://pubmed.ncbi.nlm.nih/31162712/)

[Kaemmerer et al., CEBP transcription factors in demyelinating diseases (2020)](https://pubmed.ncbi.nlm.nih/31682265/)

[Ramakrishnan et al., C/EBP family chromatin remodeling in neuronal differentiation (2018)](https://pubmed.ncbi.nlm.nih.gov/29731439/)

[Pipalia et al., Therapeutic targeting of C/EBPβ in neurodegeneration (2016)](https://pubmed.ncbi.nlm.nih.gov/26984273/)

[Ehri et al., C/EBPβ-driven microglial phenotypic transition (2021)](https://pubmed.ncbi.nlm.nih/34081741/)

[Chen et al., Astrocytic C/EBPβ in AD progression (2022)](https://pubmed.ncbi.nlm.nih.gov/35614027/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CEBPA Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CEBPA

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-cebpa
kg_node_id	CEBPA
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e2b4cbff0bca
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-cebpa'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

95%

Debates

0

Incoming

19

Outgoing

26

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CEBPA Gene

CEBPA Gene

Introduction

CEBPA Gene

Introduction

Gene And Protein Context

Molecular Functions In The Nervous System

Transcriptional Regulation

Interaction With Other Transcription Factors

Epigenetic Regulation

Physiologic Function In The Nervous System

Astrocyte Function

Microglial Activation

Neuronal Functions

Role In Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis and Demyelinating Diseases

Aging and Neurodegeneration

Disease Associations And Translational Relevance

Biomarker Potential

Therapeutic Strategies

Challenges

Experimental Models And Methods

Research Gaps And Future Directions

See Also

References

Pathway Diagram

💬 Discussion